Copyright Reports & Markets. All rights reserved.

Global Joint Pain Injections Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Joint Pain Injections Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Joint Pain Injections Market Size Growth Rate by Product
      • 1.4.2 Corticosteroid Injections
      • 1.4.3 Hyaluronic Acid Injections
      • 1.4.4 Others
    • 1.5 Market by End User
      • 1.5.1 Global Joint Pain Injections Market Size Growth Rate by End User
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Joint Pain Injections Market Size
      • 2.1.1 Global Joint Pain Injections Revenue 2014-2025
      • 2.1.2 Global Joint Pain Injections Sales 2014-2025
    • 2.2 Joint Pain Injections Growth Rate by Regions
      • 2.2.1 Global Joint Pain Injections Sales by Regions
      • 2.2.2 Global Joint Pain Injections Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Joint Pain Injections Sales by Manufacturers
      • 3.1.1 Joint Pain Injections Sales by Manufacturers
      • 3.1.2 Joint Pain Injections Sales Market Share by Manufacturers
      • 3.1.3 Global Joint Pain Injections Market Concentration Ratio (CR5 and HHI)
    • 3.2 Joint Pain Injections Revenue by Manufacturers
      • 3.2.1 Joint Pain Injections Revenue by Manufacturers (2014-2019)
      • 3.2.2 Joint Pain Injections Revenue Share by Manufacturers (2014-2019)
    • 3.3 Joint Pain Injections Price by Manufacturers
    • 3.4 Joint Pain Injections Manufacturing Base Distribution, Product Types
      • 3.4.1 Joint Pain Injections Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Joint Pain Injections Product Type
      • 3.4.3 Date of International Manufacturers Enter into Joint Pain Injections Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Joint Pain Injections Sales by Product
    • 4.2 Global Joint Pain Injections Revenue by Product
    • 4.3 Joint Pain Injections Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Joint Pain Injections Breakdown Data by End User

    6 North America

    • 6.1 North America Joint Pain Injections by Countries
      • 6.1.1 North America Joint Pain Injections Sales by Countries
      • 6.1.2 North America Joint Pain Injections Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Joint Pain Injections by Product
    • 6.3 North America Joint Pain Injections by End User

    7 Europe

    • 7.1 Europe Joint Pain Injections by Countries
      • 7.1.1 Europe Joint Pain Injections Sales by Countries
      • 7.1.2 Europe Joint Pain Injections Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Joint Pain Injections by Product
    • 7.3 Europe Joint Pain Injections by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Joint Pain Injections by Countries
      • 8.1.1 Asia Pacific Joint Pain Injections Sales by Countries
      • 8.1.2 Asia Pacific Joint Pain Injections Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Joint Pain Injections by Product
    • 8.3 Asia Pacific Joint Pain Injections by End User

    9 Central & South America

    • 9.1 Central & South America Joint Pain Injections by Countries
      • 9.1.1 Central & South America Joint Pain Injections Sales by Countries
      • 9.1.2 Central & South America Joint Pain Injections Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Joint Pain Injections by Product
    • 9.3 Central & South America Joint Pain Injections by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Joint Pain Injections by Countries
      • 10.1.1 Middle East and Africa Joint Pain Injections Sales by Countries
      • 10.1.2 Middle East and Africa Joint Pain Injections Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Joint Pain Injections by Product
    • 10.3 Middle East and Africa Joint Pain Injections by End User

    11 Company Profiles

    • 11.1 Allergan
      • 11.1.1 Allergan Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Allergan Joint Pain Injections Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Allergan Joint Pain Injections Products Offered
      • 11.1.5 Allergan Recent Development
    • 11.2 Pfizer
      • 11.2.1 Pfizer Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Pfizer Joint Pain Injections Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Pfizer Joint Pain Injections Products Offered
      • 11.2.5 Pfizer Recent Development
    • 11.3 Sanofi
      • 11.3.1 Sanofi Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Sanofi Joint Pain Injections Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Sanofi Joint Pain Injections Products Offered
      • 11.3.5 Sanofi Recent Development
    • 11.4 Anika Therapeutics
      • 11.4.1 Anika Therapeutics Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Anika Therapeutics Joint Pain Injections Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Anika Therapeutics Joint Pain Injections Products Offered
      • 11.4.5 Anika Therapeutics Recent Development
    • 11.5 Ferring
      • 11.5.1 Ferring Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Ferring Joint Pain Injections Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Ferring Joint Pain Injections Products Offered
      • 11.5.5 Ferring Recent Development
    • 11.6 Bioventus
      • 11.6.1 Bioventus Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Bioventus Joint Pain Injections Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Bioventus Joint Pain Injections Products Offered
      • 11.6.5 Bioventus Recent Development
    • 11.7 Flexion Therapeutics
      • 11.7.1 Flexion Therapeutics Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Flexion Therapeutics Joint Pain Injections Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Flexion Therapeutics Joint Pain Injections Products Offered
      • 11.7.5 Flexion Therapeutics Recent Development
    • 11.8 Zimmer Biomet Holdings
      • 11.8.1 Zimmer Biomet Holdings Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Zimmer Biomet Holdings Joint Pain Injections Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Zimmer Biomet Holdings Joint Pain Injections Products Offered
      • 11.8.5 Zimmer Biomet Holdings Recent Development
    • 11.9 SEIKAGAKU CORPORATION
      • 11.9.1 SEIKAGAKU CORPORATION Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 SEIKAGAKU CORPORATION Joint Pain Injections Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 SEIKAGAKU CORPORATION Joint Pain Injections Products Offered
      • 11.9.5 SEIKAGAKU CORPORATION Recent Development
    • 11.10 Chugai Pharmaceutical
      • 11.10.1 Chugai Pharmaceutical Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Chugai Pharmaceutical Joint Pain Injections Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Chugai Pharmaceutical Joint Pain Injections Products Offered
      • 11.10.5 Chugai Pharmaceutical Recent Development

    12 Future Forecast

    • 12.1 Joint Pain Injections Market Forecast by Regions
      • 12.1.1 Global Joint Pain Injections Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Joint Pain Injections Revenue Forecast by Regions 2019-2025
    • 12.2 Joint Pain Injections Market Forecast by Product
      • 12.2.1 Global Joint Pain Injections Sales Forecast by Product 2019-2025
      • 12.2.2 Global Joint Pain Injections Revenue Forecast by Product 2019-2025
    • 12.3 Joint Pain Injections Market Forecast by End User
    • 12.4 North America Joint Pain Injections Forecast
    • 12.5 Europe Joint Pain Injections Forecast
    • 12.6 Asia Pacific Joint Pain Injections Forecast
    • 12.7 Central & South America Joint Pain Injections Forecast
    • 12.8 Middle East and Africa Joint Pain Injections Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Joint Pain Injections Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Based on injection type, the global joint pain injections market has been segmented into corticosteroid injections, hyaluronic acid injections, and others. In terms of joint type, the global joint pain injections market has been divided into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others. Based on distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies.
      The global Joint Pain Injections market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Joint Pain Injections market based on company, product type, end user and key regions.

      This report studies the global market size of Joint Pain Injections in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Joint Pain Injections in these regions.
      This research report categorizes the global Joint Pain Injections market by top players/brands, region, type and end user. This report also studies the global Joint Pain Injections market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Allergan
      Pfizer
      Sanofi
      Anika Therapeutics
      Ferring
      Bioventus
      Flexion Therapeutics
      Zimmer Biomet Holdings
      SEIKAGAKU CORPORATION
      Chugai Pharmaceutical

      Market size by Product
      Corticosteroid Injections
      Hyaluronic Acid Injections
      Others
      Market size by End User
      Hospital Pharmacies
      Retail Pharmacies
      Online Pharmacies

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Joint Pain Injections market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Joint Pain Injections market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Joint Pain Injections companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Joint Pain Injections submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Joint Pain Injections are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Joint Pain Injections market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now